Cordatus Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cordatus Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,401	Closed	-$2.7M	–	154
2023 Q1	$2.7M	Buy	+5,401	New	+$2.58M	3.44%	8
2019 Q1	–	Sell	-7,930	Closed	-$1.48M	–	128
2018 Q4	$1.48M	Buy	+7,930	New	+$1.63M	1.05%	35

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Cordatus Wealth Management's IDXX Position: Q2 2023 in Review

Cordatus Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 5,401 shares — an estimated $2.7M sold.

Cordatus Wealth Management first reported a position in IDXX in Q4 2018 and held it in 2 quarters. The position peaked at $2.7M in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Cordatus Wealth Management reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
Cordatus Wealth Management sold 5,401 Idexx Laboratories shares in Q2 2023, an estimated $2.7M.
Cordatus Wealth Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 2 quarters.
Cordatus Wealth Management's Idexx Laboratories position peaked at $2.7M in Q1 2023.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Cordatus Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.